Tamoxifen resistance linked to high estrogen levels in utero

An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward in human research as about half of the breast cancers treated with this common cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional research.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party